Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations

Abstract For the treatment of rhinitis and asthma, a combination of Montelukast sodium and Bilastine has just been approved. Based on the first derivative of synchronous fluorescence, the current work developed a green, highly accurate, sensitive, and selective spectroscopic approach for estimating...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Sayed M. Derayea, Khalid M. Badr El-Din, Ahmed S. Ahmed, Ahmed A. Khorshed, Mohamed Oraby
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2024-01-01
Schriftenreihe:	BMC Chemistry
Schlagworte:	Bilastine Montelukast sodium Synchronous spectrofluorimetry Pharmaceutical formulation Content uniformity
Online-Zugang:	https://doi.org/10.1186/s13065-024-01116-3
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!